beta amyloid inhibitors (Oceanix)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebeta amyloid inhibitors (Oceanix)
Drug Alias NameAlzheimers therapeutics (Oceanix)
ClassificationNatural product/ExtractSmall molecules
Mechanisms of ActionBeta amyloid A4 protein inhibitors
TargetsBeta amyloid A4 protein
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOceanix Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOceanix Corp
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A